Herbas VPB

Print
EN | LT
Supplementary protection
LT - Anti-PD-L1 antikūnai ir jų panaudojimas T ląstelių funkcijos pagerinimui
EN - ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION
SPC
(11) Number of the document
(68) Number of the document 4209510
(21) Application number for Supplementary Protection Certificate PA 2024 519
(22) Date of filing the application 2024-06-13
(41) Date of publication of the application 2024-07-10
Date of publication of SPC
(24) Date of coming into effect of SPC
Applicant
(71) F. Hoffmann-La Roche AG , Grenzacherstrasse 124, 4070 Basel, CH
Grantee
(73) F. Hoffmann-La Roche AG , Grenzacherstrasse 124, 4070 Basel, CH
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/17/1220, 2017-09-21
Name of the product protected by the basic patent
(95) Atezolizumabas
Paediatric extension
Request filed SPC extension granted until Request refused
2024-06-13
Legal status
SPC application published